COMMUNIQUÉS West-GlobeNewswire

Arialief Supplement: Vitamins Reviews and Complaints for Neuropathic Pain
09/04/2025
HONOLULU, April 09, 2025 (GLOBE NEWSWIRE) -- Arialief is a premium dietary supplement specifically designed to target the root causes of neuropathic discomfort. Whether your symptoms include burning, tingling, numbness [...]
Glass House Brands Announces Hemp Research and Development Agreement with the University of California, Berkeley
09/04/2025
LONG BEACH, Calif. and TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest- [...]
M6P Therapeutics to Host Virtual KOL Event to Discuss the Lysosomal Storage Disorders Treatment Landscape on April 22, 2025
09/04/2025
Discussions will focus on Pompe Disease and M6P’s S1S3 Co-expression Platform Technology ST. LOUIS, Mo., April 09, 2025 (GLOBE NEWSWIRE) -- M6P Therapeutics (“M6PT” or “the Company”), a privately held life sciences [...]
Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)
09/04/2025
CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion U.S. Anxiety Market, and the $11.6 Billion Anxiety Market Worldwide Non- [...]
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
09/04/2025
NDA Submission Anticipated Q2 Calendar 2025 PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx- [...]
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors
09/04/2025
Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr [...]
World Leaders in Proteomics and Proteoform Biology to Convene at the 3rd International Top-Down Proteomics Symposium
09/04/2025
The Symposium will feature scientific leaders who are creating cutting edge technologies and approaches for building the bridge from genotype to phenotype. This is ushering in the era of proteoform-specific biology [...]
Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95
09/04/2025
CT-95 is a mesothelin x CD3 T cell engaging bispecific antibody CT-95 is Context’s second T cell engaging bispecific antibody to enter the clinic in 2025 PHILADELPHIA, April 09, 2025 (GLOBE NEWSWIRE) -- Context [...]
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
09/04/2025
Action Taken to Maintain Company’s Nasdaq Listing DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date [...]
Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
09/04/2025
FDA Approves EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy Total Revenue $19 million, representing +17% growth year over year FDA Approves Prior Approval [...]
Theratechnologies présente ses résultats financiers pour le premier trimestre de 2025 et passe en revue ses principales réalisations
09/04/2025
La FDA approuve EGRIFTA WR MC (la formulation F8 de la tésamoréline) pour traiter l’excès de graisse viscérale abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie Les revenus totaux s’élèvent à 19 [...]
Beta Bionics to Host Investor Event on June 22, 2025
09/04/2025
IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it will host [...]
Mars Veterinary Health Underscores Long-Term Commitment to Research & Innovation in Groundbreaking Science Impact Report
09/04/2025
Global leader in peer-reviewed veterinary research highlights progress in advancing veterinary science and clinical excellence through inaugural science report launch BIRMINGHAM, England, April 09, 2025 (GLOBE NEWSWIRE [...]
Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer
09/04/2025
WATERTOWN, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub
09/04/2025
Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 BROOMFIELD, Colo., April 09, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology [...]
Dentsply Sirona to Host First Quarter Conference Call on May 8th
09/04/2025
CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast [...]
KSQ Therapeutics Announces First Patient Dosed in Phase 1/2 Study for KSQ-004EX, a CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy
09/04/2025
Phase 1/2 clinical study will evaluate the safety and preliminary efficacy of KSQ-004EX in advanced solid tumors LEXINGTON, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- KSQ Therapeutics, Inc. (KSQ), a clinical-stage [...]
Microbix Exhibiting at ESCMID Global 2025
09/04/2025
Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program Results MISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences [...]
Preliminary results for the year ended 31 December 2024
09/04/2025
~ Strong commercial momentum underpins transformative financial performance ~ Strong 2024 financial performance in line with guidance Revenue growth of 44% to £128.8 million compared to 2023, organic revenue growth of [...]

Pages